Kulkarni, Rohit N.
- University of Chicago · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #15,733
- Rising Star
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$717.2K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#15,733
By linked amount among FY2023 PIs
Earliest Year Loaded
2001
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Kulkarni, Rohit N. as a PI. Multi-PI records show the full award amount for context.
- 5R01DK105588-09R01Contact PIRole of 12-lipoxygenase and 12-HETE signaling in beta-cell dysfunctionUniversity of Chicago · Internal Medicine (NIH department code)$655Kaward amount
- 3R01DK105588-09S1R01Contact PIRole of 12-lipoxygenase and 12-HETE signaling in beta-cell dysfunctionUniversity of Chicago · Internal Medicine (NIH department code)$62.2Kaward amount
Award organization
Organizations that administered FY2023 awards listing Kulkarni, Rohit N. as a PI.
FY2023 award administered by University of Chicago (IL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardUniversity of Chicago
- 2004$500K Cumulative Funding
- 2004$1M Cumulative Funding
- 2004Entered Top 50% NationallyRanked #5507
- 2005R01 Grant Holder
- 2014$2M Cumulative Funding
- 2014Entered Top 25% NationallyRanked #1845
- 2014Entered Top 10% NationallyRanked #1845
- 2019$5M Cumulative Funding
- 2022$10M Cumulative Funding